According to Masimo's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.11867. At the end of 2023 the company had a P/S ratio of 3.97.
Year | P/S ratio | Change |
---|---|---|
2023 | 3.97 | 3.98% |
2022 | 3.82 | -70.72% |
2021 | 13.0 | 1% |
2020 | 12.9 | 42.75% |
2019 | 9.05 | 36.27% |
2018 | 6.64 | 20.96% |
2017 | 5.49 | 13.9% |
2016 | 4.82 | 45.5% |
2015 | 3.31 | 40.78% |
2014 | 2.35 | -22.19% |
2013 | 3.02 | 23.89% |
2012 | 2.44 | -4.42% |
2011 | 2.55 | -39.54% |
2010 | 4.22 | -15.99% |
2009 | 5.03 | -2% |
2008 | 5.13 | -36.89% |
2007 | 8.13 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
![]() Thermo Fisher Scientific TMO | 4.40 | 107.51% | ๐บ๐ธ USA |
![]() General Electric GE | 1.77 | -16.67% | ๐บ๐ธ USA |
![]() ResMed RMD | 5.08 | 139.58% | ๐บ๐ธ USA |
![]() Cardinal Health CAH | 0.1038 | -95.10% | ๐บ๐ธ USA |
![]() Universal Forest Products
UFPI | 0.7783 | -63.26% | ๐บ๐ธ USA |
![]() CONMED CNMD | 2.68 | 26.51% | ๐บ๐ธ USA |
![]() Owens & Minor
OMI | 0.1260 | -94.05% | ๐บ๐ธ USA |
![]() Philips PHG | 0.9321 | -56.00% | ๐ณ๐ฑ Netherlands |